Sign in
4

Changes in Ownership

IMMUCELL CORP /DE/ Filed Acc 0001213900-22-006175

Options or other derivatives

  • President & CEO acquired 1,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BRIGHAM MICHAEL F · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-31 Grant or award : show line 1 in the form Incentive Stock Options (Right to buy) +1,000 $8.15 $8,150 1,000 D
Loading xslF345X03/doc4.xml…